Clinical Trials Sponsored by CStone Pharmaceuticals

Total 20093 results

Stony Brook University

Terminated

Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery

Postoperative Pain

United States
Stony Brook University

Active, not recruiting

Cognitive-motor Training for PD

Parkinson's Disease

United States
Stony Brook University

Terminated

Convalescent Plasma vs. Standard Plasma for COVID-19

COVID

United States
Stony Brook University

Completed

Asynchronous Techniques for the Delivery of Empirically Supported Psychotherapies

Stress | Anxiety | Depressive Symptoms | Impairment

United States
Stony Brook University

Withdrawn

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University

Withdrawn

Preventing COVID-19 in Healthcare Workers With HCQ: A RCT

Covid-19
Stony Brook University

Completed

Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study

Healthy

United States
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
Stony Brook University

Unknown

Effects of Discharge Readiness on Success Following Discharge From Sub-Acute Rehab

Discharge From Sub-acute Rehabilitation Facility

United States
Stony Brook University

Unknown

NPO and Patient Satisfaction in the Cath Lab (FAST)

Dehydration | Patient Satisfaction | Physiological Effects Secondary to Dehydration
Stony Brook University

Unknown

Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia

Hiatal Hernia

United States
Stony Brook University

Completed

The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study

Healthy

United States
Stony Brook University

Unknown

Exercise-related Post-exertional Malaise (CFS/ME)

Chronic Fatigue Syndrome

United States
Stony Brook University

Unknown

Magic Therapy to Relieve Pediatric Patient Anxiety and Improve the Hospitalization Experience

Anxiety

United States
Stony Brook University

Unknown

A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

Toxemia | Eclampsia | HELLP Syndrome | Gestational Hypertension | Superimposed Preeclampsia

United States
Stony Brook University

Unknown

Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings

Cigarette Smoking | Nicotine Addiction

United States
Stony Brook University

Unknown

Enhancing Guided Bone Regeneration by Modifying a Resorbable Membrane

Alveolar Ridge Augmentation

United States
Stony Brook University

Completed

Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology

Peri-Implantitis | Dental Implant Failed | Dental Implant Failure Nos

United States
Stony Brook University

Unknown

Study to Examine Pain Relief With Supplemental Intrathecal Morphine in TKA Patients

Acute Pain

United States
Stony Brook University

Completed

Laparascopic Assisted Colonoscopic Polypectomy

Colon Polyps

United States
Stony Brook University

Completed

Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds

Hypertension | Type 2 Diabetes | Childhood Obesity | Hypercholesterolemia

United States
Stony Brook University

Unknown

Study to Compare Reduction in Pain After Surgery With and Without Local Anesthesia During Laparoscopy

Post Operative Pain

United States
Stony Brook University

Completed

Lidocaine Patches Prior to Intravenous Insertion

Need for Intravenous Catheter

United States
Stony Brook University

Completed

HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women

Pregnancy

United States
Stony Brook University

Withdrawn

Phase II High-Dose Cyclophosphamide for Multiple Sclerosis

Multiple Sclerosis

United States
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
PPD Development, L.P.

Recruiting

DZD9008 PK Study in Hepatic Impairment Subjects

Hepatic Impairment

United States
Overseas Pharmaceuticals, Ltd.
Beijing Capton Pharmaceutical Technology Development Co., LTD

Not yet recruiting

An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Epilepsy

China
Overseas Pharmaceuticals, Ltd.
Guangzhou Health Start Pharmaceutical Techology Co.,Ltd

Not yet recruiting

An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions

Hypertension

China
Tasly GeneNet Pharmaceuticals Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Charcot-Marie-Tooth Type 1A

China
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
Auspex Pharmaceuticals, Inc.

Completed

Alternatives for Reducing Chorea in Huntington Disease (ARC-HD)

Chorea Associated With Huntington Disease

United States, Australia, Canada
Massachusetts General Hospital
Alkermes, Inc.; Otsuka America Pharmaceutical; Eisai Inc.; Janssen Pharmaceuticals and other collaborators

Recruiting

National Pregnancy Registry for Atypical Antipsychotics

Depression | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Use of Atypical Antipsychotics During Pregnancy

United States
Teva Pharmaceuticals USA
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

United States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
Auspex Pharmaceuticals, Inc.

Completed

Reducing Involuntary Movements in Participants With Tardive Dyskinesia (RIM-TD)

Tardive Dyskinesia

United States, Czechia, Germany, Hungary, Poland, Slovakia
Auspex Pharmaceuticals, Inc.

Completed

A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)

TOURETTE SYNDROME

United States
Auspex Pharmaceuticals, Inc.

Completed

Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD)

Tardive Dyskinesia

United States, Czechia, Germany, Hungary, Poland, Slovakia
Telix Pharmaceuticals (Innovations) Pty Limited
Grand Pharmaceutical (China) Co., Ltd.

Recruiting

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Prostate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate Carcinoma

China
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
Auspex Pharmaceuticals, Inc.

Completed

Aim to Reduce Movements in Tardive Dyskinesia (ARM-TD)

Tardive Dyskinesia

United States, Poland, Czechia, Slovakia
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

Mantle Cell Lymphoma

China, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
Teva Pharmaceuticals Europe

Completed

Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease (SPRINT)

Chronic Obstructive Pulmonary Disease | Asthma

Croatia, Denmark, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
Stony Brook University
DrinkHRW

Recruiting

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

Mucositis Oral

United States
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Squamous Cell Carcinoma of the Oropharynx | HPV16 Positive

Netherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

Hepatic Impairment

United States
Portola Pharmaceuticals

Withdrawn

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Venous Thromboses

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Completed

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Seizures | Tuberous Sclerosis Complex

United States

Clinical Trials Sponsored by CStone Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations